About this trial
This is a randomized, single blinded, standard of care controlled clinical trial. This project aims to compare postoperative pain control in patients in two treatment arms of rotator cuff repair: a treatment group given a nonopioid pain control regimen, and a standard of care control group given standard opioid pain control regimen
Eligibility criteria
This trial accepts healthy volunteersQualifiers
All adult patients over age 18 and scheduled for a primary or revision labral surgery
Disqualifiers
Exclusion criteria will include patients with a medical history of known allergies or intolerance to allergies or intolerance to Celebrex, Tylenol, Neurontin, dexamethasone, tramadol, substantial alcohol or drug abuse, and pregnancy, history of narcotics within 6 months of surgery, renal impairment, peptic ulcer disease, GI bleeding. Secondary exclusion criterion is an intact rotator cuff
Trial design
Parallel
Treatments tested in this trial
Celecoxib
DrugPost-Operative Non Opioid Pain Protocol
Hydrocodone-Acetaminophen
DrugTraditionally used narcotic pain protocol
Ketorolac
DrugPost-Operative Non Opioid Pain Protocol
Gabapentin
DrugPost-Operative Non Opioid Pain Protocol
Acetaminophen
DrugPost-Operative Non Opioid Pain Protocol
Diazepam
DrugPost-Operative Non Opioid Pain Protocol
Treatment groups
Trial outcomes
Primary outcomes
Pain Levels
Patients recorded pain levels 3 times per day using Visual analog scales until study completion. Average daily pain was calculated for each patient. Higher values portend worse control.
Patient-Reported Outcomes Measurement Information System
Patient-Reported Outcomes Measurement Information System Physical Interference (PROMIS PI) nightly until study completion. Average PROMIS PI values calculated nightly. A higher score indicates more pain interference.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.